8-K: Monroe Capital Corporation Holds 2024 Annual Meeting, Elects Director and Approves Share Sales Below NAV

Monroe Capital Corporation's 2024 annual meeting resulted in the election of a Class III director and approval for the potential sale of shares below net asset value.

Summary

• Monroe Capital Corporation held its 2024 annual meeting of stockholders on June 18, 2024.
• The meeting included voting on two proposals as detailed in the company's proxy statement filed on April 18, 2024.
• Theodore L. Koenig was elected as a Class III director, to serve until the 2027 annual meeting.
• Stockholders approved a proposal allowing the company to sell shares of common stock below net asset value (NAV) under certain conditions, subject to board approval, for the next twelve months.
• The vote for the director election was 9,140,058 for, 1,976,249 withheld, and 0 broker non-votes.
• The vote for the share sale proposal was 8,627,160 for, 2,135,616 against, and 353,531 abstained, including affiliate shares, and 7,844,670 for, 2,135,616 against, and 353,531 abstained, excluding affiliate shares.

Sentiment

Score: 7

Explanation: The document reflects a routine annual meeting with expected outcomes. The approval for share sales below NAV is a strategic move that could be positive for the company's growth but carries some risk of dilution for existing shareholders.

Positives

• The election of Theodore L. Koenig as a Class III director ensures continuity in the board's leadership.
• The approval to sell shares below NAV provides the company with financial flexibility to raise capital.

Negatives

• The approval to sell shares below NAV could potentially dilute existing shareholders' equity.

Risks

• Selling shares below NAV could negatively impact the company's stock price.
• The company's ability to effectively utilize the flexibility to sell shares below NAV will be critical.

Future Outlook

The company has the flexibility to sell shares below NAV for the next twelve months, subject to board approval.

Management Comments

• The company's Chief Financial Officer and Chief Investment Officer, Lewis W. Solimene, Jr., signed the report on behalf of the company.

Industry Context

The approval to sell shares below NAV is a common practice for Business Development Companies (BDCs) like Monroe Capital, allowing them to raise capital even when their stock trades below NAV. This is a strategic move to manage capital and potentially grow the business.

Comparison to Industry Standards

• Many BDCs seek shareholder approval to sell shares below NAV to manage capital effectively.
• Companies like Ares Capital Corporation (ARCC) and Main Street Capital (MAIN) also have similar authorizations to sell shares below NAV.
• The specific conditions and limitations for selling below NAV are typically outlined in the proxy statements of these companies.

Stakeholder Impact

• Shareholders may experience dilution if shares are sold below NAV.
• The company's ability to raise capital could benefit the company's growth and future performance.

Next Steps

• The company will proceed with the implementation of the approved proposals.
• The board of directors will need to approve any specific share sales below NAV.

Key Dates

Keywords

annual meeting, director election, share sale, net asset value, stockholders, common stock, capital raise, MRCC